A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy

NACompletedINTERVENTIONAL
Enrollment

952

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

February 10, 2022

Study Completion Date

February 10, 2022

Conditions
Screening ColonoscopySurveillance Colonoscopy
Interventions
PROCEDURE

Screening or Surveillance Conventionall colonoscopy

Patients in Group A (CC) will undergo Screening or Surveillance Conventual Colonoscopy, Patients in Group B (MEAC) will undergo Screening or Surveillance Colonoscopy with ME-ADPS Device

Trial Locations (11)

10032

Columbia University Irving Medical Center, New York

21202

Johns Hopkins Hospital, Baltimore

32105

GastroZentrum Lippe, Bad Salzuflen

37403

Erlanger Health System, Chattanooga

44109

MetroHealth System, Cleveland

91120

Hadassah Medical Organization, Jerusalem

Unknown

Mainz University Medical Center, Mainz

Assuta, Haifa

Department of Gastroenterology, Shamir Medical Center, Israel, Be’er Ya‘aqov

Shamir Medical Center, Be’er Ya‘aqov

The Radboud University Medical Center, Nijmegen

All Listed Sponsors
lead

Magentiq Eye LTD

INDUSTRY

NCT04640792 - A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy | Biotech Hunter | Biotech Hunter